Oryn’s lead candidate ORTD-1 is in a Phase 1b study as a subcutaneous injection for the treatment of rheumatoid arthritis (RA). A Phase 1b/2 study has begun evaluating intravenous ORTD-1 for the treatment of COVID-19 pneumonia.
A Life-Changing Class of its Own
From our evolutionary ancestors to a new world of bio-inspired therapeutics.
Learn MoreThe Latest
Oryn Therapeutics
Oryn is introducing a paradigm changing approach to drug development with a revolutionary new class of therapeutics, Orynotides. The company’s mission is to improve quality of life in patients by creating safer, more efficacious treatments for autoimmune and chronic inflammatory diseases, drug resistant infections, and cancer.
Learn More About The CompanyOrynotides – Therapeutic Benefit, Reduced Risk
Orynotides are a novel, patented class of therapeutics bioinspired by naturally occurring peptides discovered in non-human primates. Orynotides are safe (non-toxic), stable, non-immunogenic, and easy to produce. Therapeutic applications include diseases for which current treatments have black box warnings and limited efficacy. Thus, Orynotides offer a new and revolutionary therapeutic approach for treatment of chronic and life-threatening diseases.
Learn More About Orynotides TechnologyHighly Stable
Easy to Synthesize
Broad Range of Applications
Non-Toxic
Non-Immunogenic
Immunomodulatory
Therapeutic Areas
Orynotide ORTD-1 is being developed as a novel treatment for rheumatoid arthritis, COVID-19, and other systemic inflammatory diseases. Other Orynotides are being developed for viral, bacterial, and fungal infections, inflammatory bowel disease, and cancer.
Learn More About The Therapeutic ApplicationsDrug Pipeline
Experienced Team
Led by the founders, Oryn Therapeutics is a growing group of experienced scientists and business leaders, with an exceptional Scientific Advisory Board.
Contact Us
Oryn Therapeutics welcomes discussion and dialogue with interested parties regarding our scientific research and business activities. Please use the following contact information or the form on this page to reach out to us with any questions or inquiry you may have about our company. Our team looks forward to hearing from you.
Oryn Therapeutics
3333 Vaca Valley Parkway
Suite 400
Vacaville, CA 95688